» Articles » PMID: 30793050

NRLMF: Beta-distribution-rescored Neighborhood Regularized Logistic Matrix Factorization for Improving the Performance of Drug-target Interaction Prediction

Overview
Specialty Biochemistry
Date 2019 Feb 23
PMID 30793050
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Techniques for predicting interactions between a drug and a target (protein) are useful for strategic drug repositioning. Neighborhood regularized logistic matrix factorization (NRLMF) is one of the state-of-the-art drug-target interaction prediction methods; it is based on a statistical model using the Bernoulli distribution. However, the prediction is not accurate when drug-target interaction pairs have less interaction information (e.g., the sum of the number of ligands for a target and the number of target proteins for a drug). This study aimed to address this issue by proposing NRLMF with beta distribution rescoring (NRLMF), which is an algorithm to improve the score of NRLMF. The score of NRLMF is equivalent to the value of the original NRLMF score when the concentration of the beta distribution becomes infinity. The beta distribution is known as a conjugative prior distribution of the Bernoulli distribution and can reflect the amount of interaction information to its shape based on Bayesian inference. Therefore, in NRLMF, the beta distribution was used for rescoring the NRLMF score. In the evaluation experiment, we measured the average values of area under the receiver operating characteristics and area under precision versus recall and the 95% confidence intervals. The performance of NRLMF was found to be better than that of NRLMF in the four types of benchmark datasets. Thus, we concluded that NRLMF improved the prediction accuracy of NRLMF. The source code is available at https://github.com/akiyamalab/NRLMFb.

Citing Articles

MSI-DTI: predicting drug-target interaction based on multi-source information and multi-head self-attention.

Zhao W, Yu Y, Liu G, Liang Y, Xu D, Feng X Brief Bioinform. 2024; 25(3).

PMID: 38762789 PMC: 11102638. DOI: 10.1093/bib/bbae238.


Challenges and Perspectives in Target Identification and Mechanism Illustration for Chinese Medicine.

Guo X, An S, Bao F, Xu T Chin J Integr Med. 2023; 29(7):644-654.

PMID: 36809500 DOI: 10.1007/s11655-023-3629-9.


SSELM-neg: spherical search-based extreme learning machine for drug-target interaction prediction.

Hu L, Fu C, Ren Z, Cai Y, Yang J, Xu S BMC Bioinformatics. 2023; 24(1):38.

PMID: 36737694 PMC: 9896467. DOI: 10.1186/s12859-023-05153-y.


Hyperbolic matrix factorization improves prediction of drug-target associations.

Poleksic A Sci Rep. 2023; 13(1):959.

PMID: 36653463 PMC: 9849222. DOI: 10.1038/s41598-023-27995-5.


A geometric deep learning model for display and prediction of potential drug-virus interactions against SARS-CoV-2.

Das B, Kutsal M, Das R Chemometr Intell Lab Syst. 2022; 229:104640.

PMID: 36042844 PMC: 9400382. DOI: 10.1016/j.chemolab.2022.104640.


References
1.
Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

2.
Gonen M . Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization. Bioinformatics. 2012; 28(18):2304-10. DOI: 10.1093/bioinformatics/bts360. View

3.
Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita K, Itoh M, Kawashima S . From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2005; 34(Database issue):D354-7. PMC: 1347464. DOI: 10.1093/nar/gkj102. View

4.
Schomburg I, Chang A, Ebeling C, Gremse M, Heldt C, Huhn G . BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res. 2003; 32(Database issue):D431-3. PMC: 308815. DOI: 10.1093/nar/gkh081. View

5.
Li J, Zheng S, Chen B, Butte A, Swamidass S, Lu Z . A survey of current trends in computational drug repositioning. Brief Bioinform. 2015; 17(1):2-12. PMC: 4719067. DOI: 10.1093/bib/bbv020. View